Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1201

1.

Aggressive statin therapy in multicenter and effectiveness for the reduction of intra-myocardial damage caused by non-ST elevation acute coronary syndrome: AMERICA study.

Hara H, Nakamura M, Yokouchi I, Kimura K, Nemoto N, Ito S, Ono T, Itaya H, Shiba M, Wada M, Iijima R, Yamamoto M, Yamamoto M, Hara H, Takagi T, Asahara T, Mitsuo K, Kobayashi N, Sugi K.

Ther Adv Cardiovasc Dis. 2009 Oct;3(5):357-65. doi: 10.1177/1753944709338893. Epub 2009 Jul 28.

PMID:
19638365
2.

Impact of statin therapy on coronary intervention for non-ST elevation acute coronary syndrome with decreased low-density lipoprotein cholesterol.

Hara H, Nakamura M, Yokouchi I, Kimura K, Nemoto N, Ito S, Ono T, Shiba M, Wada M, Tsuji T, Komatsu H, Iijima R, Nakajima R, Yamamoto M, Yamamoto M, Yoshitama T, Takagi T, Hara H, Sugi K.

J Cardiol. 2007 Mar;49(3):115-23.

PMID:
17444137
3.

The beneficial effect of high loading dose of rosuvastatin before percutaneous coronary intervention in patients with acute coronary syndrome.

Yun KH, Jeong MH, Oh SK, Rhee SJ, Park EM, Lee EM, Yoo NJ, Kim NH, Ahn YK, Jeong JW.

Int J Cardiol. 2009 Nov 12;137(3):246-51. doi: 10.1016/j.ijcard.2008.06.055. Epub 2008 Aug 15.

PMID:
18706705
4.

Intensive cholesterol lowering with statin improves the outcomes of percutaneous coronary intervention in patients with acute coronary syndrome.

Jia XW, Fu XH, Zhang J, Gu XS, Fan WZ, Wu WL, Hao GZ, Li SQ, Jiang YF.

Chin Med J (Engl). 2009 Mar 20;122(6):659-64.

PMID:
19323930
5.

Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study.

Pasceri V, Patti G, Nusca A, Pristipino C, Richichi G, Di Sciascio G; ARMYDA Investigators.

Circulation. 2004 Aug 10;110(6):674-8. Epub 2004 Jul 26.

6.

Treatment modalities of non-ST-elevation acute coronary syndromes in the real world. Results of the prospective R.OS.A.I.-2 registry.

Registro Osservazionale Angina Instabile Investigators.

Ital Heart J. 2003 Nov;4(11):782-90.

PMID:
14699708
7.

Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction.

Briguori C, Colombo A, Airoldi F, Violante A, Focaccio A, Balestrieri P, Paolo Elia P, Golia B, Lepore S, Riviezzo G, Scarpato P, Librera M, Bonizzoni E, Ricciardelli B.

Eur Heart J. 2004 Oct;25(20):1822-8.

8.

Effects of receipt of chronic statin therapy before the onset of acute myocardial infarction: a retrospective study in patients undergoing primary percutaneous coronary intervention.

Ishii H, Ichimiya S, Kanashiro M, Aoyama T, Ogawa Y, Murakami R, Amano T, Naruse K, Matsubara T, Murohara T.

Clin Ther. 2006 Nov;28(11):1812-9.

PMID:
17213001
9.
11.

Use of statins prior to percutaneous coronary intervention reduces myonecrosis and improves clinical outcome.

Chang SM, Yazbek N, Lakkis NM.

Catheter Cardiovasc Interv. 2004 Jun;62(2):193-7.

PMID:
15170709
13.
15.

Low incidence of minor myocardial damage associated with coronary stenting detected by serum troponin T comparable to that with balloon coronary angioplasty.

Ohnishi N, Iwasaki K, Kusachi S, Hirami R, Matano S, Ohnishi H, Takeda K, Kita T, Sakakibara N, Tsuji T.

Jpn Heart J. 1998 Mar;39(2):139-46.

PMID:
9687822
16.

Postprocedural hyperglycemia in ST elevation myocardial infarction submitted to percutaneous coronary intervention: a prognostic indicator and a marker of metabolic derangement.

Lazzeri C, Chiostri M, Sori A, Valente S, Gensini GF.

J Cardiovasc Med (Hagerstown). 2010 Jan;11(1):7-13. doi: 10.2459/JCM.0b013e32832d83b3.

PMID:
19829142
17.

Preprocedural statin medication reduces the extent of periprocedural non-Q-wave myocardial infarction.

Herrmann J, Lerman A, Baumgart D, Volbracht L, Schulz R, von Birgelen C, Haude M, Heusch G, Erbel R.

Circulation. 2002 Oct 22;106(17):2180-3.

18.

Lack of efficacy of clopidogrel pre-treatment in the prevention of myocardial damage after elective stent implantation.

van der Heijden DJ, Westendorp IC, Riezebos RK, Kiemeneij F, Slagboom T, van der Wieken LR, Laarman GJ.

J Am Coll Cardiol. 2004 Jul 7;44(1):20-4.

19.

Protective role of chronic statin therapy in reducing myocardial damage during percutaneous coronary intervention.

Auguadro C, Manfredi M, Scalise F, Mortara A, Specchia G.

J Cardiovasc Med (Hagerstown). 2006 Jun;7(6):416-21.

PMID:
16721204
20.

Assessment of left ventricle diastolic function in myocardial infarction patients treated with primary angioplasty.

Misztal M, Stopyra K, Gackowski A, Zmudka K, Piwowarska W.

Cardiol J. 2009;16(5):440-6.

PMID:
19753523
Items per page

Supplemental Content

Write to the Help Desk